News

CorVista Health is Hiring Chief of Staff

This role is an integral part of the growth and success of a dynamic, fast paced startup at the cusp of commercialization.  We seek a strong Chief of Staff who will work closely with the CEO on execution of all projects associated with the success of the company, from administrative to HR support, stakeholder communications, and beyond.  We seek a professional with a “can do” attitude who is detail-oriented, resourceful, organized and holds a high degree of professionalism.

THE ROLE

RESPONSIBILITIES

  • Provide high-level administrative support to the CEO and leadership team who move fast and are building a rapidly growing Health technology company
  • Improve current processes and coordinate organizational procedures for optimized efficiency and productivity
  • Project manager on new facility in Washington, DC
  • Maintains executive appointment schedule by planning and scheduling meetings, conferences, and travel
  • Manages and maintains executive calendar
  • Tracks and prioritizes projects perform supporting research and effectively communicates within the organization
  • Execute special or continuous research and data analysis. Analyzes problems, determines approach, compiles and analyzes data, and prepares reports / recommendations for action by a management team.
  • Assist in HR-related activities; work with our consultant in establishing formal processes and procedures
  • Manage and gathering of confidential onboarding documentation checklists/procedures
  • Manage confidential termination checklists/procedures
  • Assist/lead board-related communications/activities, board meetings
  • Assist/administer shareholder communications program, shareholder meetings, etc.
  • Maintain equity documents in CARTA system
  • Assist/administer public relations/corporate communications activities
  • Assist/administer communications program with strategics, bankers, etc.
  • Assist/administer contracts management and some negotiations
  • Provide support in JLabs office

 

QUALIFICATIONS

  • Demonstrated competency in project management
  • Entrepreneurial and willingness to “roll up sleeves”
  • Be extremely computer savvy
  • Have excellent written and verbal communication skills
  • Be flexible and take initiative on projects
  • Have outgoing and creative personality
  • Be able to multi-task and work on several projects at once
  • Have a desire to get involved and understand the needs of a growing business
  • Have basic experience with social media
  • Possesses excellent communication skills; both written and verbal
  • Problem Solver – Quantitative Aptitude, Logical Reasoning
  • Experience creating systems, processes and procedures- Abstract Reasoning
  • Detail-oriented, organized, and self-starting
  • Bachelor’s degree required
  • Commutable distance to Washington DC

To Apply: https://careers.mullingsgroup.com/position/corvista-chief-of-staff/

Recent News

05/14/2025

Civica to start Chesterfield lab construction this summer, eyes Petersburg plant expansion

Nearly three years after announcing plans to build a laboratory in Chesterfield to support its manufacturing operations in Petersburg, Civica Rx is readying plans to kick off the project’s construction. The Utah-based nonprofit drugmaker said it will break ground this summer on a 50,000-square-foot facility at 11731 Meadowville Lane, in the Meadowville Technology Park near Chester.

05/07/2025

Adial Pharmaceuticals raises $2.75M

Glen Allen biopharma company Adial Pharmaceuticals Inc. (NASDAQ: ADIL) has raised $2.75 million from an institutional investor. The company, which specializes in therapies for addiction and related disorders, said it will use the new funding for working capital and general corporate purposes. The name of the investor was not disclosed, but Adial said a “health

05/07/2025

Adovate Granted New U.S. Patent for Therapeutic Uses of A2B Receptor Antagonists

Adovate, LLC (“Adovate” or the “Company”), a biopharmaceutical company developing novel therapeutics targeting adenosine receptors involved in major diseases, today announced that Patent Number 12,269,828 B2 was issued by the United States Patent and Trademark Office. This newly issued patent covers therapeutic uses of the Company’s lead molecule ADO-5030 and thousands of other novel molecules